Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 482 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
482
Total Funding
$1.6B
Avg Funding
$63.7M
Cities
21

Export 482 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Toronto, Canada
$50.0M
raised

Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$250.0M
raised

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$380.0M
raised

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$393K
raised

New treatment for blood diseases, such as leukemia and lymphoma.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Philadelphia, United States
$30.0M
raised

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

Sep 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 482 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Copenhagen, Denmark
$6.6M
raised

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$110.0M
raised

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Dallas, United States
$4.0M
raised

Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$21.0M
raised

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Sep 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Penarth, United Kingdom
$9.4M
raised

RenalytixAI is a developer of artificial intelligence-enabled clinical diagnostic solutions for kidney health.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 482 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Lexington, United States
$60.0M
raised

Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Chatswood, Australia
$807K
raised

Next Science pioneers innovative, proprietary technologies to address the problem of biofilm.

Sep 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Miramar Beach, United States
$1.5M
raised

HCW Biologics is developing immunotherapies to lengthen healthspan by disrupting the link between cellular senescence and disease.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cincinnati, United States
$12.9M
raised

Onconetix is a biotechnology company that focuses on research and development of universal flu vaccines.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$115.0M
raised

PepGen is empowering nucleic acid therapeutics to go the distance.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 482 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Toronto, Canada
$7.9M
raised

PharmaTher Holdings pecializes in the development and commercialization of ketamine-based medicines.

Sep 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wilmette, United States
$135.0M
raised

Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Los Altos, United States
$100.0M
raised

Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$27.0M
raised

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

Sep 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Baltimore, United States
$7.0M
raised

TNF Pharmaceuticals is researching groundbreaking treatments to address serious and debilitating autoimmune and inflammatory illnesses.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 482 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Bromma, Sweden
$3.1M
raised

OncoZenge develops better products for the supportive care of cancer patients.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oceanside, United States
$10.0M
raised

Therapeutic Solutions International is a biotechnology company engaged in the development of products for females.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$100.0M
raised

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

Sep 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Redwood City, United States
$150.0M
raised

Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$1.2M
raised

Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 482 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 482 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked